A public notice from CDSCO has put India's booming aesthetic clinic industry on alert. Any product supplied in injectable form does not qualify as a cosmetic under Indian law.
The Budget acknowledges the growing burden of non-communicable diseases such as cancer, diabetes and autoimmune disorders, alongside the increasing global reliance on biologic medicines.
With these measures, India is well-positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, he said.
These medicines were among those consumed by children in the reported cluster of cases.
The recommendation follows a probe into child deaths in Madhya Pradesh allegedly linked to contaminated cough syrups.
The announcement follows a comprehensive and in-depth scientific review of India’s vaccine regulatory system by a team of international experts from various countries, led by the WHO.
A team of international experts from various countries, led by WHO (HQ) in Geneva, arrived at this conclusion following a comprehensive and in-depth scientific review of India’s vaccine regulatory system conducted from September 16 to 20.
India, long regarded as the pharmacy of the world, faces yet another challenge as its drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has flagged over 50 widely used drugs as substandard or counterfeit.
RSV is a highly contagious virus that can lead to serious respiratory illness in infants and is also the leading cause of hospitalisation in infants worldwide.
The Central Drugs Standard Control Organisation (CDSCO) has approved AstraZeneca Pharma India's liver cancer drug Tremelimumab Concentrate to be administered intravenously, the company said on Thursday.
